Novartis AG
NVS119.040USD
+0.490+0.41%
시장 운영 시간 （ET）시세는 15분 지연됩니다
230.44B시가총액
17.92P/E TTM
자세한 내용은 Novartis AG 회사
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
회사 정보
종목 코드 NVS
회사 이름Novartis AG
상장일May 07, 2001
CEODr. Vasant (Vas) Narasimhan, M.D.
직원 수75883
유형Ordinary Share
회계 연도 종료May 07
주소Lichtstrasse 35
도시BASEL
증권 거래소Johannesburg Stock Exchange
국가Switzerland
우편 번호4056
전화41613241111
웹사이트https://www.novartis.com/
종목 코드 NVS
상장일May 07, 2001
CEODr. Vasant (Vas) Narasimhan, M.D.
회사 임원
이름
이름/직위
직위
주식 보유
변동
Ms. Elizabeth (Liz) Doherty
Ms. Elizabeth (Liz) Doherty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ton Buechner
Mr. Ton Buechner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Aaron (Ronny) Gal, Ph.D.
Mr. Aaron (Ronny) Gal, Ph.D.
Chief Strategy and Growth Officer, Member of the Executive Committee
Chief Strategy and Growth Officer, Member of the Executive Committee
--
--
Mr. Victor Bulto
Mr. Victor Bulto
President - US, Member of the Executive Committee
President - US, Member of the Executive Committee
--
--
Ms. Charlotte Pamer- Wieser, Ph.D.
Ms. Charlotte Pamer- Wieser, Ph.D.
Corporate Secretary
Corporate Secretary
--
--
Ms. Karen L. Hale
Ms. Karen L. Hale
Chief Legal Officer, Member of the Executive Committee
Chief Legal Officer, Member of the Executive Committee
--
--
Mr. Frans van Houten
Mr. Frans van Houten
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Elizabeth Mcnally
Ms. Elizabeth Mcnally
Director
Director
--
--
Dr. Steffen Lang, Ph.D.
Dr. Steffen Lang, Ph.D.
President - Operations, Member of the Executive Committee
President - Operations, Member of the Executive Committee
--
--
Mr. Harry Kirsch
Mr. Harry Kirsch
Chief Financial Officer, Member of the Executive Committee
Chief Financial Officer, Member of the Executive Committee
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Ms. Elizabeth (Liz) Doherty
Ms. Elizabeth (Liz) Doherty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ton Buechner
Mr. Ton Buechner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Aaron (Ronny) Gal, Ph.D.
Mr. Aaron (Ronny) Gal, Ph.D.
Chief Strategy and Growth Officer, Member of the Executive Committee
Chief Strategy and Growth Officer, Member of the Executive Committee
--
--
Mr. Victor Bulto
Mr. Victor Bulto
President - US, Member of the Executive Committee
President - US, Member of the Executive Committee
--
--
Ms. Charlotte Pamer- Wieser, Ph.D.
Ms. Charlotte Pamer- Wieser, Ph.D.
Corporate Secretary
Corporate Secretary
--
--
Ms. Karen L. Hale
Ms. Karen L. Hale
Chief Legal Officer, Member of the Executive Committee
Chief Legal Officer, Member of the Executive Committee
--
--
수익 분석
통화: USD마지막 업데이트: Sun, Jul 6
통화: USD마지막 업데이트: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Rest of portfolio
2.40B
18.11%
Cardiovascular, Renal and Metabolism - Entresto
2.26B
17.09%
Immunology - Cosentyx
1.53B
11.59%
Oncology -Kisqali
956.00M
7.22%
Neuroscience - Kesimpta
899.00M
6.79%
Other
5.19B
39.20%
지역별USD
이름
수익
비율
US
5.71B
43.16%
Europe
3.90B
29.51%
Asia / Africa / Australasia
2.77B
20.95%
Canada and Latin America
844.00M
6.38%
사업별
지역별
사업별USD
이름
수익
비율
Rest of portfolio
2.40B
18.11%
Cardiovascular, Renal and Metabolism - Entresto
2.26B
17.09%
Immunology - Cosentyx
1.53B
11.59%
Oncology -Kisqali
956.00M
7.22%
Neuroscience - Kesimpta
899.00M
6.79%
Other
5.19B
39.20%
주식 보유 통계
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
주주
주주 유형
주주
주주
비율
Dodge & Cox
0.61%
PRIMECAP Management Company
0.54%
Dimensional Fund Advisors, L.P.
0.44%
Fisher Investments
0.35%
Loomis, Sayles & Company, L.P.
0.28%
Other
97.77%
주주
주주
비율
Dodge & Cox
0.61%
PRIMECAP Management Company
0.54%
Dimensional Fund Advisors, L.P.
0.44%
Fisher Investments
0.35%
Loomis, Sayles & Company, L.P.
0.28%
Other
97.77%
주주 유형
주주
비율
Investment Advisor
3.21%
Investment Advisor/Hedge Fund
3.02%
Research Firm
0.54%
Hedge Fund
0.34%
Bank and Trust
0.13%
Pension Fund
0.03%
Family Office
0.02%
Other
92.72%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
1941
140.71M
7.27%
+2.13M
2025Q1
1953
141.07M
7.20%
+870.45K
2024Q4
1926
134.00M
6.78%
-9.24M
2024Q3
1858
134.89M
6.74%
-11.71M
2024Q2
1840
139.20M
6.87%
-9.16M
2024Q1
1808
141.30M
6.92%
-7.93M
2023Q4
1811
141.99M
6.94%
-15.97M
2023Q3
1775
150.92M
7.33%
-7.18M
2023Q2
1759
150.74M
7.28%
-24.15M
2023Q1
1762
167.49M
7.98%
-13.01M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Dodge & Cox
11.82M
0.6%
-396.56K
-3.25%
Mar 31, 2025
PRIMECAP Management Company
10.38M
0.53%
-642.16K
-5.82%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
8.61M
0.44%
+422.87K
+5.17%
Mar 31, 2025
Fisher Investments
6.76M
0.35%
+4.76M
+237.66%
Mar 31, 2025
Loomis, Sayles & Company, L.P.
5.50M
0.28%
-73.87K
-1.32%
Mar 31, 2025
Franklin Mutual Advisers, LLC
4.86M
0.25%
+601.89K
+14.12%
Mar 31, 2025
Morgan Stanley Smith Barney LLC
3.52M
0.18%
-68.47K
-1.91%
Mar 31, 2025
Parametric Portfolio Associates LLC
3.00M
0.15%
+22.57K
+0.76%
Mar 31, 2025
Wellington Management Company, LLP
2.99M
0.15%
-656.53K
-18.00%
Mar 31, 2025
Managed Account Advisors LLC
2.91M
0.15%
-41.63K
-1.41%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Wed, Aug 6
마지막 업데이트: Wed, Aug 6
이름
비율
VanEck Pharmaceutical ETF
5.55%
Amplify International Enhanced Dividend Income ETF
3.61%
Abacus FCF International Leaders ETF
3.23%
Altrius Global Dividend ETF
2.51%
Invesco International Dividend Achievers ETF
2.22%
Freedom Day Dividend ETF
1.95%
Avantis International Large Cap Value ETF
1.7%
Fundamentals First ETF
1.69%
SP Funds S&P World (ex-US) ETF
1.62%
DFA Dimensional Internatl High Profitability ETF
1.58%
더 보기
VanEck Pharmaceutical ETF
비율5.55%
Amplify International Enhanced Dividend Income ETF
비율3.61%
Abacus FCF International Leaders ETF
비율3.23%
Altrius Global Dividend ETF
비율2.51%
Invesco International Dividend Achievers ETF
비율2.22%
Freedom Day Dividend ETF
비율1.95%
Avantis International Large Cap Value ETF
비율1.7%
Fundamentals First ETF
비율1.69%
SP Funds S&P World (ex-US) ETF
비율1.62%
DFA Dimensional Internatl High Profitability ETF
비율1.58%
주식 배당금
지난 5년 동안 총
36.74B
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Feb 20, 2025
NVS.NB Approximate final Cash Dividend of gross USD 3.869541 going ex on Mar 12, 2025
Mar 12, 2025
May 01, 2025
Mar 12, 2025
Feb 12, 2024
NVS.NB Final Cash Dividend of gross USD 3.739544 paid on Apr 19, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Apr 19, 2024
Mar 07, 2024
Feb 02, 2023
NVS.NB Final Cash Dividend of gross USD 3.498699 paid on Mar 20, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 20, 2023
Mar 09, 2023
Feb 04, 2022
NVS.NB Final Cash Dividend of gross USD 3.32525 paid on Mar 17, 2022 going ex on Mar 08, 2022
Mar 09, 2022
Mar 17, 2022
Mar 08, 2022
Jan 26, 2021
NVS.NB Final Cash Dividend of gross USD 3.199072 paid on Mar 15, 2021 going ex on Mar 04, 2021
Mar 05, 2021
Mar 15, 2021
Mar 04, 2021
Jan 31, 2020
NVS.NB Final Cash Dividend of gross USD 3.087366 paid on Mar 12, 2020 going ex on Mar 03, 2020
Mar 04, 2020
Mar 12, 2020
Mar 03, 2020
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
